Skip to main content
Filing year 2023

THE WITTEK RESEARCH FOUNDATION FOR HYPERTROPHIC CARDIOMYOPATHY INC

Tenafly, New Jersey·EIN 86-1682122·NTEE H43 · Medical Research·501(c)(3)
Total revenue
$74k
Total assets
$71k
Total expenses
$41k
Reported officers
3

Reported officers (all unpaid)

No paid executives reported in 2023. THE WITTEK RESEARCH FOUNDATION FOR HYPERTROPHIC CARDIOMYOPATHY INC reported 3 unpaid officers and board members on its 990-EZ.

President and Founder
Treasurer
Secretary
Sector benchmark

What Medical Research executives earn

THE WITTEK RESEARCH FOUNDATION FOR HYPERTROPHIC CARDIOMYOPATHY INC reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable medical research organization nationwide earns a median of $120,264.

25th percentile
$48k
Median
$120,264
75th percentile
$252k
90th percentile
$466k

These are medical research sector-wide figures, not this organization's reported pay. Based on 1,118 organizations across 1,118 filings (2020 – 2024).

See full Medical Research compensation data
FAQ

Common questions about THE WITTEK RESEARCH FOUNDATION FOR HYPERTROPHIC CARDIOMYOPATHY INC

What are THE WITTEK RESEARCH FOUNDATION FOR HYPERTROPHIC CARDIOMYOPATHY INC's revenue and expenses?

In 2023, THE WITTEK RESEARCH FOUNDATION FOR HYPERTROPHIC CARDIOMYOPATHY INC reported $74k in total revenue and $41k in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.